| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.9M | -20.8% |
| Cost of Revenue | $351K | -48.5% |
| Gross Profit | $1.5M | -9.3% |
| R&D Expense | $32K | — |
| SG&A Expense | $2.0M | -65.7% |
| Operating Income | -$1.2M | +94.5% |
| Interest Expense | $300K | +3.1% |
| Net Income | -$1.5M | +93.3% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $40K | +164.9% |
| Inventory | $107K | -3.7% |
| Current Assets | $251K | -18.4% |
| Total Assets | $411K | -19.2% |
| Current Liabilities | $4.1M | +11.9% |
| Long-term Debt | $1.2M | +4.1% |
| Total Liabilities | $4.9M | +27.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $39K | +112.0% |
| Capital Expenditures | $9K | -95.2% |
| Investing Cash Flow | -$59K | +68.6% |
| Financing Cash Flow | $33K | -92.5% |
| Free Cash Flow | $30K | +105.8% |
| -$4.5M |
| -34.3% |